The combined use of GLP-1 agonists and gastrin for regulating blood glucose levels

Details for Australian Patent Application No. 2005207870 (hide)

Owner Waratah Pharmaceuticals, Inc.

Inventors Hew, Yin; Cruz, Antonio; Pastrak, Aleksandra

Agent Spruson & Ferguson

Pub. Number AU-B-2005207870

PCT Pub. Number WO2005/072045

Priority 60/540,803 30.01.04 US; 60/540,804 30.01.04 US

Filing date 28 January 2005

Wipo publication date 11 August 2005

Acceptance publication date 19 August 2010

International Classifications

C07K 14/595 (2006.01) Peptides having more than 20 amino acids

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/072045 Priority application(s): WO2005/072045

19 August 2010 Application Accepted

  Published as AU-B-2005207870

16 December 2010 Standard Patent Sealed

25 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005207871-Powder formulations

2005207867-Knot tying tool